期刊文献+

^(99)Tc^m标记的ND1重组单链抗体在荷人结肠癌裸鼠体内分布及放射免疫显像研究 被引量:2

Studies on biodistribution and radioimmunoimaging of ^(99)Tc^m labelled ND1 recombined scFvs in nu mice bearing human colonic carcinoma
下载PDF
导出
摘要 目的:探讨99Tcm标记的ND1重组单链抗体(scFv)在荷人结肠癌裸鼠模型体内的生物学分布及放射免疫显像。方法:①荷人结肠癌裸鼠移植瘤模型的建立。②抗体的标记及标记率的测定。③将99Tcm-ND1重组scFv经腹腔和尾静脉注入荷瘤裸鼠体内,分别于注射后1h、3h、8h进行放射免疫显像。取各脏器及肿瘤组织,计算TKNT比值。结果:①99Tcm-ND1重组scFv标记率为85%。②注射后1h肿瘤K血比值为2.62±0.23,3h肿瘤K血比值为3.90±0.25,8h肿瘤K血比值为0.58±0.17。腹腔和尾静脉注射组大肠TKNT值差异有显著性(P<0.05和P<0.005)。99Tcm-ND1重组scFv在荷瘤裸鼠体内生物学分布检测结果示腹腔注入后3h各脏器TKNT比值较高。③放射免疫显像。显像阳性率达100%。以3h显像最清晰。结论9:9Tcm-ND1重组scFv对结肠癌具有良好的亲和力,可望作为结肠癌诊断、预后判定的导向载体。并为临床早期特异性诊断结肠肿瘤提供新的有效手段。 Objective: To study biodistribution and radioimmunoimaging of 99Tcm labeled ND1 recombined scFvs in nude mice bearing human colonic carcinoma.Methods: ①To establish human colonic carcinoma xenograft model in nude mice bearing human colonic carcinoma.②Labelled antibody and determination of labelling rate.ND1 scFv was labelled by direct labelling method,paper chromatography determined labelling rate.③On the base of model of nude mice bearing human colorectal carcinoma,99Tcm-ND1 recombined scFvs was administed...
出处 《中国临床医学影像杂志》 CAS 北大核心 2006年第S1期41-43,共3页 Journal of China Clinic Medical Imaging
关键词 结肠肿瘤 放射性核素显像 colonic neoplasms radionuclide imaging
  • 相关文献

参考文献3

二级参考文献14

共引文献20

同被引文献18

  • 1刘长征,张汝森,张勇.氨胺-T法和Iodogen法碘标记抗体的比较[J].中山医科大学学报,1995,16(3):43-46. 被引量:4
  • 2侯俊然,何蔼,詹希美.ScFv噬菌体抗体库技术研究进展及其在寄生虫学上的应用[J].国外医学(寄生虫病分册),2005,32(4):187-189. 被引量:4
  • 3苗积生,沈毅,吴吉勇.放射性核素标记单克隆抗体(McAb)免疫反应活性分数的测定[J].同位素,1996,9(2):85-88. 被引量:7
  • 4魏莉,罗荣城.放射性核素标记抗CD20单克隆抗体治疗B细胞淋巴瘤的研究进展[J].国际放射医学核医学杂志,2006,30(3):153-157. 被引量:5
  • 5Nordlund MS,Fermer C,Nilsson O,et al.Production and characterization of monoclonal antibodies for immunoassay of the lung cancer marker proGRP.Tumour Biol,2007,28(2):100-110.
  • 6Yamaguchi H,Soda H,Kitazaki T,et al.Serum progastrin-releasing peptide levels followed by whole-body positron emission tomography detects early recurrence of small-cell lung cancer.Respirology,2007,12(1):137-139.
  • 7Satoh H,Kagohashi K,Kurishima K,et al.Comparison of neuronespecific enolase and pro-gastrin releasing peptide in the prognostic evaluation of small cell lung cancer patients.Clin Oncol,2006,18(9):720.
  • 8Davda JP,Jain M,Batra SK,et al.A physiologically based pharmacokinetic(PBPK) model to characterize and predict the disposition of monoclonal antibody CC49 and its single chain Fv constructs.Int Immunopharmacol,2008,8(3):401-413.
  • 9Ferl GZ,Kenanova V,Wu AM,et al.A two-tiered physiologically based model for dually labeled single-chain Fv-Fc antibody fragments.Mol Cancer Ther,2006,5(6):1550-1558.
  • 10Nordlund M S, Fermer C, Nilsson O, et al. Production and characterization of monoclonal antibodies for immunoassay of the lung cancer marker proGRP . Tumour Biol, 2007, 28 ( 2 ) : 100-110.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部